Harnessing Artificial Intelligence for the Future of Precision Medicine: Transforming Patient-Centric Care Through Data- Driven Innovation

Abstract

Advancements in artificial intelligence (AI) are steadily reshaping the landscape of modern medicine, particularly in the context of precision healthcare. In 2024, the global AI healthcare market surged to $ 32.34 billion, with 80 % of hospitals adopting AI to enhance patient care and workflow efficiency. By drawing on complex datasets that range from genomic profiles to real-time health signals, AI is paving the way for more personalized diagnosis, treatment, and prevention strategies. In clinical settings, technologies such as digital twins and federated learning enable safer, privacy-preserving models of care while improving disease outcome predictions and therapy responses. Moreover, the integration of AI with wearable devices and Internet of Things (IoT) platforms supports continuous patient monitoring and early detection of chronic and acute conditions. These innovations facilitate proactive health interventions and empower individuals to take charge of their health beyond clinical environments. AI’s influence extends to drug discovery and dosing optimization, making treatment plans more effective and cost-efficient. However, these technological gains are accompanied by pressing ethical and regulatory considerations, ranging from algorithmic bias and data privacy to trust in AI systems and the need for flexible, forward-thinking policies. Addressing these concerns requires robust governance frameworks and collaborative efforts across disciplines. Altogether, AI-driven precision medicine marks a shift from generalized treatment models toward targeted, patient- centered care, with the potential to enhance therapeutic outcomes, reduce healthcare disparities, and contribute meaningfully to global health improvement.